How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Artificial intelligence is entering the era of self-improvement. On Thursday afternoon, OpenAI released a new cutting-edge coding model that the company said assisted in its own creation.

How and Why to Invest in ETFs: Demystifying the Vehicle Taking Markets by Storm Silver pulls back from $32.55 resistance, with key support at $31.81. Traders await NFP data for the next market move.

Building a full-stack application with one of the best vibe coding platforms can be as easy as describing what you are trying to build to a friend. Simply explain what you are trying to create using ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...